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Multiple myeloma is characterized by the disordered
production of immunoglobulins by malignant plasma
cells located in bone marrow. Localized form of malig-
nant plasma cell tumors are known as extramedullary
plasmacytomas. They represent unusual accumu-
lation of neoplastic monoclonal plasma cells causing
soft-tissue mass. Extramedullary plasmacytomas occur
mainly in the upper respiratory tract. Deposits in the
urogenital tract (bladder, kidney) have also been re-
ported. However, plasmacytoma involving primarily
urethral tissue is an extremely rare condition with only
seven cases having been reported so far. Herein, we
describe the clinical presentation and characteristics
of a patient who was diagnosed with primary plas-
macytoma of the urethra.
CASE PRESENTATION
A 51-year-old man presented to our clinic with termi-
nal hematuria and a palpable penile mass. Except for
mild dysuria, the patient had no obstructive or irrita-
tive voiding symptoms. He had no history of recurrent
urinary tract infection, calculi, or urinary inconti-
nence. Physical examination revealed a palpable mass
located on the ventral aspect of the penis that was
painless, immobile, 1.5cm in length and with indefinite
borders. Routine biochemical and hematologic param-
eters were within normal ranges. Chest X-ray find-
ings were normal. Microscopic examination of urine
sediment revealed > 15 red blood cells and 2 white
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Plasmacytomas of the urethra are extremely rare neoplasias; they may occur as isolated tumors
or concomitantly with generalized multiple myeloma. Herein, we describe the clinical presenta-
tion and characteristics of a patient with primary plasmacytoma of the urethra. A 51-year-old
man presented with terminal hematuria and a palpable penile mass. Magnetic resonance ure-
thrography revealed a 3-cm long stenotic segment along which the urethral mucosa was found to
be irregular. On urethroscopy, papillary mucosal projections extending to the presphincteric area
were noted. Lesions were found to be composed primarily of neoplastic plasma cells capable of
producing mainly lambda light chain. Upon diagnosis, the patient received external beam radia-
tion therapy targeting the pelvic region. The lesion diminished in size progressively during the
treatment course. He was disease-free after 6 months. Although it is a relatively rare disease, pri-
mary urethral plasmacystoma should be considered in the differential diagnosis of urethral
tumors and radiation therapy should be an integral part of the treatment strategy.
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blood cells per high power field. Ultrasonography,
intravenous pyelography and computed tomography
(CT) of the abdomen and pelvis excluded all possible
pathologies. After these basic evaluations in the con-
text of hematuria work-up, we decided to perform
penile magnetic resonance imaging (MRI) since the
patient had a palpable penile mass.
Penile MRI showed a 3.5-cm long, irregular bulbar
urethral mass with contrast enhancement. No other
space-occupying lesion was noted. In addition, a path-
ologically enlarged (2cm in greatest dimension) lymph
node was detected in the left inguinal region. MR
urethrography revealed a 3-cm long stenotic segment
along which the urethral mucosa was found to be
irregular. This narrow segment was localized at the
proximal end of the penile urethra (Figure 1). Similar
findings were revealed by conventional retrograde ure-
thrography. On endoscopic examination of the urethra,
papillary mucosal projections originating from the
level of the fossa navicularis, extending to the pre-
sphincteric area, were noted (Figure 2). The bladder
was free of any neoplastic lesion. Multiple biopsy spec-
imens from the papillary lesions were obtained using
cold-cup biopsy forceps. On histopathologic exami-
nation, the lesions were found to be composed pri-
marily of neoplastic plasma cells (Figure 3). Apart
from plasma cells, AL type amyloid deposits were
also noted. On antigenic analysis, 20% of the cellular
population was CD20(+), which signified B lympho-
cyte phenotype. The rest of the population was com-
posed of CD38(+) plasma cells. The majority of the
plasma cells (90%) harbored lambda light chain. Dif-
fuse AL type amyloid deposits which stained posi-
tively with Congo red were also of diagnostic value.
This positive reaction persisted after the specimens
were treated with permanganate, which was strongly
suggestive of primary amyloidosis.
To ascertain the diagnosis of extramedullary plas-
macytoma, bone marrow biopsy was performed. Plas-
ma cell infiltration was not evident in bone marrow.
Whole body bone scintigraphy was negative for me-
tastatic osseous lesion. No osteolytic lesions typical
of multiple myeloma was noted on X-ray evaluation
Figure 1. Magnetic resonance urethrography shows a 3-cm long
stenotic segment along which the urethral mucosa was found to
be irregular (arrow).
Figure 2. Urethroscopic image of papillary mucosal projections
partially obstructing the lumen.
Figure 3. Neoplastic plasma cell deposits (hematoxylin & eosin,
360×).
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of the axial skeleton. Serum protein electrophoresis
was negative for monoclonal “M” spike, which is one
of the major diagnostic criteria of multiple myeloma.
Bence-Jones proteinuria, which signifies the excess
excretion of immunoglobulin light chains in urine,
was not found in the patient. To confirm the neoplastic
nature of the lesion, positron emission tomography
was carried out. Fluorodeoxyglucose uptake was sig-
nificantly higher along the penile shaft and left inguinal
region. This finding demonstrated the active prolif-
erative nature of the lesion. Based on these findings,
a diagnosis of solitary extramedullary plasmacytoma
was made.
On diagnosis, the patient received a total dose of
40 Gy (200 cGy/fr × 20fr) of external beam radiation
therapy targeting the perineal region, which was toler-
ated well. His symptoms subsided after the initiation
of radiotherapy. The lesion progressively diminished
in size during the treatment period. This alteration
was evident both clinically and radiologically. After 
a follow-up period of 6 months, he was disease-free.
On control imaging studies, there was no sign of
residual disease or progression.
DISCUSSION
Multiple myeloma is a malignant hematologic dis-
ease of plasma cells that is characterized by the pres-
ence of monoclonal immunoglobulins or light chains
in the serum and urine. Its main feature is bony de-
struction caused by focal plasma cell tumors known
as plasmacytomas. Malignant plasma cells have the
potential to disseminate and form metastatic deposits
in extraosseous tissues. Dissemination of the neoplas-
tic plasma cells should be ruled out by bone marrow
aspiration/biopsy, X-ray study of the axial skeleton,
immunoelectrophoresis of serum and urine before a
diagnosis of primary extramedullary plasmacytoma
can be made. Extramedullary plasmacytoma more
commonly affects males between the ages of 50 and 70.
Its main site of occurence is the upper respiratory tract
(76%). Other sites include lymph nodes and spleen
(6%), the lower respiratory tract (4%), skin and sub-
cutaneous areas (3.5%), gastrointestinal tract (3%) and
the thyroid gland (3%) [1]. The urethra is an extremely
rare localization for this kind of tumor. To our knowl-
edge, only seven cases of primary urethral plasmacy-
toma have been reported in the English literature [2–4].
In the urinary tract, bladder and kidney plasma-
cytomas are treated with various combinations of
surgery, chemotherapy and radiotherapy. Involvement
of the regional lymph nodes is a frequent finding in
extramedullary plasmacytomas. This is the reason
why regional lymph nodes should also be included
in the radiation field for plasmacytomas [1]. Optimal
treatment of renal plasmacytomas consists of radical
nephrectomy and local irradiation of the tumor bed
[5,6]. Meanwhile, plasma cell deposits involving the
bladder can be managed by surgery with or without
radiotherapy or radiochemotherapy [7].
The overall recurrence rate for extramedullary
plasmacytomas was found to be 30% in a review of the
literature [8]. In general, the 10-year survival rate of
patients with solitary plasmacytoma is estimated to
be in the range of 50–60% [8]. However, it was reported
that plasmacytomas can potentially disseminate in
90% of cases up to 20 years after the initial diagnosis
[9]. For this reason, lifelong follow-up of these pa-
tients is mandatory. Once dissemination is evident,
chemotherapy may be a treatment alternative.
To date, six cases of urethral plasmacytoma were
treated with surgery (transurethral resection) and ad-
juvant radiotherapy and one with only radiotherapy.
Plasmacytomas are known to be radiosensitive neo-
plastic lesions. Our patient with urethral plasmacy-
toma received radiotherapy including the site of nodal
involvement. Wiltshaw noted that only less than 2%
of extramedullary plasmacytomas were refractory to
radiation therapy with additional lymph node sur-
gery [8]. Our case is the second in whom local con-
trol was achieved with solely radiotherapy during 
a follow-up period of 6 months. The first case was a
35-year-old man who received radiotherapy with a
total dose of 45 Gy. He remained disease-free without
any therapy-related side effects after a follow-up of
36 months [10]. However, radiotherapy cannot be 
regarded as the primary treatment modality for ure-
thral plasmacytoma based on the outcome of these
two cases with limited follow-up. Nonetheless, radio-
therapy may be a curative tool for these patients with
minimal morbidity.
In conclusion, owing to the radiosensitive nature of
extramedullary plasma cell deposits, radiation therapy
should be an integral part of the treatment strategy
for urethral plasmacytoma. Since there is a continuing
risk of distant metastasis throughout the natural course
of this disease, lifelong follow-up is mandatory.
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